The COVID-19 pandemic is causing a delay in recruitment and completion of investigational drug clinical trials. Several pharmaceutical companies have announced delays due to the virus. In some cases new trials are being postponed and in other cases existing trials are being halted or arrangements made to provide study medication to patients. The pool of patients and those willing to volunteer is smaller while the pandemic impacts the health and movement of patients. Healthcare providers and healthcare facilities also have less time and space to use for trials.
Chloroquine and Hydroxychloroquine